Schedule 13D ownership disclosure

GALERA THERAPEUTICS INC

Security class unavailable · CUSIP: 36338D108

Event date: 2019-11-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,083,712
Percent of class
12.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-065570
Form type
SC 13D
Filer
Galera Therapeutics, Inc.
CIK
CIK 1563577
Filed
Nov 20, 2019
Reporting period
Nov 12, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub